XLO XILIO THERAPEUTICS INC Delisting Actions 8-K Filing 2024 - Delisting Xilio Therapeutics, Inc. received a deficiency letter from Nasdaq stating that the bid price for the company's common stock has closed below $1.00 per share for the last 30 consecutive business days, which may lead to delisting.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC